Insider Trades176 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Sell | LQDA | Jason Adair | Chief Business Officer | 688 | $87.53 | $6.0B | -28.70% | +215.63% | $60.2K | -0.32% | 10b5-1 | Stalk |
| Jul 27, 2026 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 1,600 | $87.53 | $6.0B | -28.70% | +215.63% | $140.0K | -0.94% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Sanjeev Khindri | Chief Development Officer | 1,185 | $71.51 | $6.0B | -28.70% | +215.63% | $84.7K | -0.88% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Jason Adair | Chief Business Officer | 7,863 | $71.51 | $6.0B | -28.70% | +215.63% | $562.3K | -1.54% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 7,864 | $71.51 | $6.0B | -28.70% | +215.63% | $562.4K | -2.80% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 9,002 | $71.51 | $6.0B | -28.70% | +215.63% | $643.7K | -2.32% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 9,539 | $71.51 | $6.0B | -28.70% | +215.63% | $682.1K | -2.14% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 9,926 | $71.51 | $6.0B | -28.70% | +215.63% | $709.8K | -2.31% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Russell Schundler | General Counsel | 14,738 | $71.51 | $6.0B | -28.70% | +215.63% | $1.1M | -1.11% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Michael Kaseta | CFO and COO | 20,430 | $71.51 | $6.0B | -28.70% | +215.63% | $1.5M | -2.44% | 10b5-1 | Stalk |
| Jul 13, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 35,249 | $71.51 | $6.0B | -28.70% | +215.63% | $2.5M | -1.38% | 10b5-1 | Stalk |
| Jun 11, 2026 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 24,880 | $70.28 | $6.0B | -28.70% | +215.63% | $1.7M | -8.65% | 10b5-1 | Stalk |
| Jun 8, 2026 | Sell | LQDA | Sanjeev Khindri | Chief Development Officer | 4,134 | $65.46 | $6.0B | -28.70% | +215.63% | $270.6K | -5.80% | 10b5-1 | Stalk |
| Jun 1, 2026 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 276 | $60.87 | $6.0B | -28.70% | +215.63% | $16.8K | -0.19% | 10b5-1 | Stalk |
| May 27, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 6,428 | $62.18 | $6.0B | -28.70% | +215.63% | $399.7K | -0.61% | 10b5-1 | Stalk |
| May 21, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 75,000 | $61.01 | $6.0B | -28.70% | +215.63% | $4.6M | -2.28% | 10b5-1 | Stalk |
| May 18, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 75,000 | $58.91 | $6.0B | -28.70% | +215.63% | $4.4M | -2.13% | 10b5-1 | Stalk |
| May 13, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 75,000 | $57.32 | $6.0B | -28.70% | +215.63% | $4.3M | -2.00% | 10b5-1 | Stalk |
| May 8, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 75,000 | $45.89 | $6.0B | -28.70% | +215.63% | $3.4M | -1.89% | 10b5-1 | Stalk |
| May 5, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 75,000 | $40.99 | $6.0B | -28.70% | +215.63% | $3.1M | -1.79% | 10b5-1 | Stalk |
| Apr 27, 2026 | Sell | LQDA | Jason Adair | Chief Business Officer | 688 | $41.65 | $6.0B | -28.70% | +215.63% | $28.7K | -0.32% | 10b5-1 | Stalk |
| Apr 27, 2026 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 1,576 | $37.78 | $6.0B | -28.70% | +215.63% | $59.5K | -0.89% | 10b5-1 | Stalk |
| Apr 17, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 18,839 | $40.60 | $6.0B | -28.70% | +215.63% | $765.0K | -1.31% | 10b5-1 | Stalk |
| Apr 14, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 53,300 | $40.21 | $6.0B | -28.70% | +215.63% | $2.1M | -1.20% | 10b5-1 | Stalk |
| Apr 14, 2026 | Sell | LQDA | Michael Kaseta | CFO and COO | 232,361 | $25.68 | $6.0B | -28.70% | +215.63% | $6.0M | -2.01% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 4,557 | $38.37 | $6.0B | -28.70% | +215.63% | $174.9K | -2.44% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 5,101 | $38.37 | $6.0B | -28.70% | +215.63% | $195.7K | -2.35% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | LQDA | Jason Adair | Chief Business Officer | 7,301 | $38.37 | $6.0B | -28.70% | +215.63% | $280.1K | -2.48% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 9,220 | $38.37 | $6.0B | -28.70% | +215.63% | $353.8K | -3.59% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 10,547 | $38.34 | $6.0B | -28.70% | +215.63% | $404.4K | -2.34% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | LQDA | Russell Schundler | General Counsel | 13,692 | $38.37 | $6.0B | -28.70% | +215.63% | $525.4K | -1.90% | 10b5-1 | Stalk |
| Apr 13, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 54,177 | $39.06 | $6.0B | -28.70% | +215.63% | $2.1M | -1.84% | 10b5-1 | Stalk |
| Apr 10, 2026 | Sell | LQDA | Michael Kaseta | CFO and COO | 66,600 | $26.28 | $6.0B | -28.70% | +215.63% | $1.8M | -1.27% | 10b5-1 | Stalk |
| Apr 9, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 25,000 | $40.12 | $6.0B | -28.70% | +215.63% | $1.0M | -1.62% | 10b5-1 | Stalk |
| Apr 9, 2026 | Sell | LQDA | Michael Kaseta | CFO and COO | 267,578 | $21.52 | $6.0B | -28.70% | +215.63% | $5.8M | +0.00% | 10b5-1 | Stalk |
| Mar 23, 2026 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 35,314 | $20.72 | $6.0B | -28.70% | +215.63% | $731.6K | -0.22% | 10b5-1 | Stalk |
| Mar 13, 2026 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 16,261 | $38.00 | $6.0B | -28.70% | +215.63% | $617.9K | -9.88% | — | Stalk |
| Mar 13, 2026 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 35,365 | $36.30 | $6.0B | -28.70% | +215.63% | $1.3M | -16.85% | — | Stalk |
| Mar 9, 2026 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 160,000 | $19.27 | $6.0B | -28.70% | +215.63% | $3.1M | +0.00% | 10b5-1 | Stalk |
| Mar 2, 2026 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 276 | $30.58 | $6.0B | -28.70% | +215.63% | $8.4K | -0.17% | 10b5-1 | Stalk |
| Mar 2, 2026 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 445 | $30.58 | $6.0B | -28.70% | +215.63% | $13.6K | -0.25% | 10b5-1 | Stalk |
| Mar 2, 2026 | Sell | LQDA | Jason Adair | Chief Business Officer | 689 | $30.58 | $6.0B | -28.70% | +215.63% | $21.1K | -0.32% | 10b5-1 | Stalk |
| Mar 2, 2026 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 827 | $30.58 | $6.0B | -28.70% | +215.63% | $25.3K | -0.44% | 10b5-1 | Stalk |
| Mar 2, 2026 | Sell | LQDA | Russell Schundler | General Counsel | 1,073 | $30.58 | $6.0B | -28.70% | +215.63% | $32.8K | -0.17% | 10b5-1 | Stalk |
| Mar 2, 2026 | Sell | LQDA | Michael Kaseta | CFO and COO | 1,165 | $30.58 | $6.0B | -28.70% | +215.63% | $35.6K | -0.28% | 10b5-1 | Stalk |
| Jan 26, 2026 | Sell | LQDA | Jason Adair | Chief Business Officer | 688 | $41.65 | $6.0B | -28.70% | +215.63% | $28.7K | -0.32% | 10b5-1 | Stalk |
| Jan 26, 2026 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 1,580 | $41.65 | $6.0B | -28.70% | +215.63% | $65.8K | -0.88% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 11,047 | $37.43 | $6.0B | -28.70% | +215.63% | $413.5K | -5.37% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 13,165 | $37.43 | $6.0B | -28.70% | +215.63% | $492.8K | -6.85% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Jason Adair | Chief Business Officer | 13,548 | $37.43 | $6.0B | -28.70% | +215.63% | $507.1K | -5.13% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 20,533 | $37.43 | $6.0B | -28.70% | +215.63% | $768.6K | -8.14% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 21,142 | $37.43 | $6.0B | -28.70% | +215.63% | $791.3K | -7.55% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Russell Schundler | General Counsel | 27,289 | $37.43 | $6.0B | -28.70% | +215.63% | $1.0M | -3.82% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Michael Kaseta | CFO and COO | 36,932 | $37.43 | $6.0B | -28.70% | +215.63% | $1.4M | -7.11% | 10b5-1 | Stalk |
| Jan 12, 2026 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 66,610 | $37.43 | $6.0B | -28.70% | +215.63% | $2.5M | -4.80% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 221 | $32.19 | $6.0B | -28.70% | +215.63% | $7.1K | -0.16% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 303 | $32.19 | $6.0B | -28.70% | +215.63% | $9.8K | -0.20% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 693 | $32.19 | $6.0B | -28.70% | +215.63% | $22.3K | -0.39% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 831 | $32.19 | $6.0B | -28.70% | +215.63% | $26.7K | -0.53% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 1,072 | $32.19 | $6.0B | -28.70% | +215.63% | $34.5K | -0.18% | 10b5-1 | Stalk |
| Dec 1, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 1,166 | $32.19 | $6.0B | -28.70% | +215.63% | $37.5K | -0.33% | 10b5-1 | Stalk |
| Nov 18, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 71,312 | $17.96 | $6.0B | -28.70% | +215.63% | $1.3M | +0.00% | 10b5-1 | Stalk |
| Nov 7, 2025 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 29,004 | $25.09 | $6.0B | -28.70% | +215.63% | $727.7K | -8.05% | — | Stalk |
| Nov 5, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 71,381 | $27.00 | $6.0B | -28.70% | +215.63% | $1.9M | -14.54% | — | Stalk |
| Oct 27, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 692 | $22.93 | $6.0B | -28.70% | +215.63% | $15.9K | -0.39% | 10b5-1 | Stalk |
| Oct 27, 2025 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 1,073 | $22.93 | $6.0B | -28.70% | +215.63% | $24.6K | -0.58% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 1,238 | $23.41 | $6.0B | -28.70% | +215.63% | $29.0K | -0.66% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 1,691 | $23.41 | $6.0B | -28.70% | +215.63% | $39.6K | -1.18% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 3,670 | $23.41 | $6.0B | -28.70% | +215.63% | $85.9K | -1.66% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 4,900 | $23.41 | $6.0B | -28.70% | +215.63% | $114.7K | -2.63% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 5,327 | $23.41 | $6.0B | -28.70% | +215.63% | $124.7K | -1.87% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 7,839 | $23.41 | $6.0B | -28.70% | +215.63% | $183.5K | -1.27% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 11,630 | $23.41 | $6.0B | -28.70% | +215.63% | $272.3K | -2.79% | 10b5-1 | Stalk |
| Oct 13, 2025 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 20,261 | $23.41 | $6.0B | -28.70% | +215.63% | $474.3K | -1.72% | 10b5-1 | Stalk |
| Sep 2, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 1,063 | $29.05 | $6.0B | -28.70% | +215.63% | $30.9K | -0.18% | 10b5-1 | Stalk |
| Sep 2, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 1,148 | $29.05 | $6.0B | -28.70% | +215.63% | $33.3K | -0.32% | 10b5-1 | Stalk |
| Sep 2, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 70,692 | $28.63 | $6.0B | -28.70% | +215.63% | $2.0M | -10.52% | 10b5-1 | Stalk |
| Aug 29, 2025 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 209 | $29.05 | $6.0B | -28.70% | +215.63% | $6.1K | -0.15% | 10b5-1 | Stalk |
| Aug 29, 2025 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 296 | $29.05 | $6.0B | -28.70% | +215.63% | $8.6K | -0.16% | 10b5-1 | Stalk |
| Aug 28, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 20,000 | $27.85 | $6.0B | -28.70% | +215.63% | $557.1K | -7.41% | 10b5-1 | Stalk |
| Aug 28, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 26,508 | $27.88 | $6.0B | -28.70% | +215.63% | $739.0K | -6.68% | 10b5-1 | Stalk |
| Aug 15, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 20,000 | $26.18 | $6.0B | -28.70% | +215.63% | $523.7K | -5.31% | 10b5-1 | Stalk |
| Aug 5, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 30,000 | $20.00 | $6.0B | -28.70% | +215.63% | $600.1K | -7.38% | 10b5-1 | Stalk |
| Jul 28, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 454 | $19.54 | $6.0B | -28.70% | +215.63% | $8.9K | -0.23% | 10b5-1 | Stalk |
| Jul 28, 2025 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 1,063 | $19.54 | $6.0B | -28.70% | +215.63% | $20.8K | -0.57% | 10b5-1 | Stalk |
| Jul 21, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 2,526 | $14.54 | $6.0B | -28.70% | +215.63% | $36.7K | -0.93% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Dana Boyle | Chief Accounting Officer | 1,193 | $14.28 | $6.0B | -28.70% | +215.63% | $17.0K | -0.63% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 2,576 | $14.28 | $6.0B | -28.70% | +215.63% | $36.8K | -1.17% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Sarah Krepp | Chief Human Resource Officer | 2,673 | $14.28 | $6.0B | -28.70% | +215.63% | $38.2K | -1.84% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 4,797 | $14.28 | $6.0B | -28.70% | +215.63% | $68.5K | -1.85% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 5,327 | $14.28 | $6.0B | -28.70% | +215.63% | $76.1K | -1.71% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 7,836 | $14.28 | $6.0B | -28.70% | +215.63% | $111.9K | -1.26% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 11,580 | $14.28 | $6.0B | -28.70% | +215.63% | $165.4K | -2.43% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 20,252 | $14.28 | $6.0B | -28.70% | +215.63% | $289.2K | -1.69% | 10b5-1 | Stalk |
| Jul 14, 2025 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 20,252 | $14.28 | $6.0B | -28.70% | +215.63% | $289.2K | -1.69% | 10b5-1 | Stalk |
| Jun 4, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 3,597 | $16.97 | $6.0B | -28.70% | +215.63% | $61.0K | -1.60% | 10b5-1 | Stalk |
| Jun 4, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 6,656 | $16.97 | $6.0B | -28.70% | +215.63% | $113.0K | -2.50% | 10b5-1 | Stalk |
| Jun 4, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 7,597 | $16.97 | $6.0B | -28.70% | +215.63% | $128.9K | -2.38% | 10b5-1 | Stalk |
| Jun 4, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 8,460 | $16.97 | $6.0B | -28.70% | +215.63% | $143.6K | -1.34% | 10b5-1 | Stalk |
| Jun 4, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 14,777 | $16.97 | $6.0B | -28.70% | +215.63% | $250.8K | -3.01% | 10b5-1 | Stalk |
| Jun 4, 2025 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 30,610 | $16.97 | $6.0B | -28.70% | +215.63% | $519.5K | -2.49% | 10b5-1 | Stalk |
| Jun 2, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 451 | $16.74 | $6.0B | -28.70% | +215.63% | $7.5K | -0.24% | 10b5-1 | Stalk |
| Jun 2, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 581 | $16.74 | $6.0B | -28.70% | +215.63% | $9.7K | -0.26% | 10b5-1 | Stalk |
| Jun 2, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 859 | $16.74 | $6.0B | -28.70% | +215.63% | $14.4K | -0.21% | 10b5-1 | Stalk |
| Jun 2, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 923 | $16.74 | $6.0B | -28.70% | +215.63% | $15.5K | -0.16% | 10b5-1 | Stalk |
| Apr 28, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 455 | $14.24 | $6.0B | -28.70% | +215.63% | $6.5K | -0.25% | 10b5-1 | Stalk |
| Apr 21, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 2,450 | $13.67 | $6.0B | -28.70% | +215.63% | $33.5K | -0.92% | 10b5-1 | Stalk |
| Apr 15, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 3,406 | $13.57 | $6.0B | -28.70% | +215.63% | $46.2K | -1.56% | 10b5-1 | Stalk |
| Apr 14, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 1,856 | $13.57 | $6.0B | -28.70% | +215.63% | $25.2K | -0.87% | 10b5-1 | Stalk |
| Apr 14, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 3,714 | $13.57 | $6.0B | -28.70% | +215.63% | $50.4K | -1.38% | 10b5-1 | Stalk |
| Apr 14, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 5,964 | $13.57 | $6.0B | -28.70% | +215.63% | $80.9K | -1.03% | 10b5-1 | Stalk |
| Apr 14, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 8,283 | $13.57 | $6.0B | -28.70% | +215.63% | $112.4K | -2.05% | 10b5-1 | Stalk |
| Apr 14, 2025 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 14,130 | $13.57 | $6.0B | -28.70% | +215.63% | $191.7K | -1.38% | 10b5-1 | Stalk |
| Mar 3, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 451 | $15.45 | $6.0B | -28.70% | +215.63% | $7.0K | -0.24% | 10b5-1 | Stalk |
| Mar 3, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 592 | $15.45 | $6.0B | -28.70% | +215.63% | $9.1K | -0.26% | 10b5-1 | Stalk |
| Mar 3, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 874 | $15.45 | $6.0B | -28.70% | +215.63% | $13.5K | -0.21% | 10b5-1 | Stalk |
| Mar 3, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 930 | $15.45 | $6.0B | -28.70% | +215.63% | $14.4K | -0.16% | 10b5-1 | Stalk |
| Jan 27, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 445 | $14.20 | $6.0B | -28.70% | +215.63% | $6.3K | -0.25% | 10b5-1 | Stalk |
| Jan 21, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 2,445 | $13.00 | $6.0B | -28.70% | +215.63% | $31.8K | -0.90% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | LQDA | Jason Adair | Chief Business Officer | 4,809 | $11.78 | $6.0B | -28.70% | +215.63% | $56.7K | -1.95% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 6,249 | $11.78 | $6.0B | -28.70% | +215.63% | $73.6K | -1.79% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 8,362 | $11.78 | $6.0B | -28.70% | +215.63% | $98.5K | -2.85% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | LQDA | Russell Schundler | General Counsel | 16,393 | $11.78 | $6.0B | -28.70% | +215.63% | $193.1K | -2.37% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 22,343 | $11.78 | $6.0B | -28.70% | +215.63% | $263.2K | -1.76% | 10b5-1 | Stalk |
| Jan 14, 2025 | Sell | LQDA | Michael Kaseta | CFO and COO | 23,370 | $11.78 | $6.0B | -28.70% | +215.63% | $275.3K | -4.34% | 10b5-1 | Stalk |
| Dec 2, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 455 | $11.51 | $6.0B | -28.70% | +215.63% | $5.2K | -0.36% | 10b5-1 | Stalk |
| Dec 2, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 546 | $11.51 | $6.0B | -28.70% | +215.63% | $6.3K | -0.33% | 10b5-1 | Stalk |
| Dec 2, 2024 | Sell | LQDA | Russell Schundler | General Counsel | 1,063 | $11.51 | $6.0B | -28.70% | +215.63% | $12.2K | -0.21% | 10b5-1 | Stalk |
| Dec 2, 2024 | Sell | LQDA | Michael Kaseta | CFO and COO | 1,091 | $11.51 | $6.0B | -28.70% | +215.63% | $12.6K | -0.34% | 10b5-1 | Stalk |
| Oct 28, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 459 | $11.31 | $6.0B | -28.70% | +215.63% | $5.2K | -0.39% | 10b5-1 | Stalk |
| Oct 28, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 459 | $11.31 | $6.0B | -28.70% | +215.63% | $5.2K | -0.39% | 10b5-1 | Stalk |
| Oct 18, 2024 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 2,526 | $11.19 | $6.0B | -28.70% | +215.63% | $28.3K | -1.22% | 10b5-1 | Stalk |
| Oct 14, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 1,146 | $11.11 | $6.0B | -28.70% | +215.63% | $12.7K | -0.74% | — | Stalk |
| Oct 14, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 1,527 | $11.11 | $6.0B | -28.70% | +215.63% | $17.0K | -0.99% | 10b5-1 | Stalk |
| Oct 14, 2024 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 2,260 | $11.11 | $6.0B | -28.70% | +215.63% | $25.1K | -1.08% | 10b5-1 | Stalk |
| Oct 14, 2024 | Sell | LQDA | Russell Schundler | General Counsel | 2,576 | $11.11 | $6.0B | -28.70% | +215.63% | $28.6K | -0.53% | 10b5-1 | Stalk |
| Oct 14, 2024 | Sell | LQDA | Michael Kaseta | CFO and COO | 3,892 | $11.11 | $6.0B | -28.70% | +215.63% | $43.2K | -1.24% | 10b5-1 | Stalk |
| Oct 14, 2024 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 8,053 | $11.11 | $6.0B | -28.70% | +215.63% | $89.5K | -0.98% | 10b5-1 | Stalk |
| Sep 3, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 455 | $9.50 | $6.0B | -28.70% | +215.63% | $4.3K | -0.36% | — | Stalk |
| Sep 3, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 546 | $9.50 | $6.0B | -28.70% | +215.63% | $5.2K | -0.33% | 10b5-1 | Stalk |
| Sep 3, 2024 | Sell | LQDA | Russell Schundler | General Counsel | 710 | $9.50 | $6.0B | -28.70% | +215.63% | $6.7K | -0.14% | 10b5-1 | Stalk |
| Sep 3, 2024 | Sell | LQDA | Michael Kaseta | CFO and COO | 1,079 | $9.50 | $6.0B | -28.70% | +215.63% | $10.3K | -0.33% | 10b5-1 | Stalk |
| Jul 26, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 1,833 | $11.44 | $6.0B | -28.70% | +215.63% | $21.0K | -1.59% | 10b5-1 | Stalk |
| Jul 19, 2024 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 1,873 | $11.13 | $6.0B | -28.70% | +215.63% | $20.8K | -0.89% | 10b5-1 | Stalk |
| Jul 12, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 1,146 | $12.53 | $6.0B | -28.70% | +215.63% | $14.4K | -0.74% | 10b5-1 | Stalk |
| Jul 12, 2024 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 1,470 | $12.53 | $6.0B | -28.70% | +215.63% | $18.4K | -0.69% | 10b5-1 | Stalk |
| Jul 12, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 1,528 | $12.53 | $6.0B | -28.70% | +215.63% | $19.1K | -1.00% | 10b5-1 | Stalk |
| Jul 12, 2024 | Sell | LQDA | Russell Schundler | General Counsel | 1,985 | $12.53 | $6.0B | -28.70% | +215.63% | $24.9K | -0.41% | 10b5-1 | Stalk |
| Jul 12, 2024 | Sell | LQDA | Michael Kaseta | CFO and COO | 3,906 | $12.53 | $6.0B | -28.70% | +215.63% | $48.9K | -1.23% | 10b5-1 | Stalk |
| Jul 12, 2024 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 8,053 | $12.53 | $6.0B | -28.70% | +215.63% | $100.9K | -0.97% | 10b5-1 | Stalk |
| Jun 3, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 455 | $14.55 | $6.0B | -28.70% | +215.63% | $6.6K | -0.37% | — | Stalk |
| Jun 3, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 546 | $14.55 | $6.0B | -28.70% | +215.63% | $7.9K | -0.33% | 10b5-1 | Stalk |
| Jun 3, 2024 | Sell | LQDA | Russell Schundler | General Counsel | 710 | $14.55 | $6.0B | -28.70% | +215.63% | $10.3K | -0.14% | 10b5-1 | Stalk |
| Jun 3, 2024 | Sell | LQDA | Michael Kaseta | CFO and COO | 1,094 | $14.55 | $6.0B | -28.70% | +215.63% | $15.9K | -0.33% | 10b5-1 | Stalk |
| Apr 19, 2024 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 1,649 | $13.68 | $6.0B | -28.70% | +215.63% | $22.6K | -0.77% | 10b5-1 | Stalk |
| Apr 12, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 1,189 | $14.58 | $6.0B | -28.70% | +215.63% | $17.3K | -0.76% | 10b5-1 | Stalk |
| Apr 12, 2024 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 1,525 | $14.58 | $6.0B | -28.70% | +215.63% | $22.2K | -0.71% | 10b5-1 | Stalk |
| Apr 12, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 1,585 | $14.58 | $6.0B | -28.70% | +215.63% | $23.1K | -1.03% | 10b5-1 | Stalk |
| Apr 12, 2024 | Sell | LQDA | Russell Schundler | General Counsel | 2,060 | $14.58 | $6.0B | -28.70% | +215.63% | $30.0K | -0.42% | 10b5-1 | Stalk |
| Apr 12, 2024 | Sell | LQDA | Michael Kaseta | CFO and COO | 3,136 | $14.58 | $6.0B | -28.70% | +215.63% | $45.7K | -0.99% | 10b5-1 | Stalk |
| Apr 12, 2024 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 8,360 | $14.58 | $6.0B | -28.70% | +215.63% | $121.9K | -1.00% | 10b5-1 | Stalk |
| Mar 18, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 4,657 | $15.81 | $6.0B | -28.70% | +215.63% | $73.6K | -1.73% | — | Stalk |
| Mar 18, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 6,108 | $15.82 | $6.0B | -28.70% | +215.63% | $96.6K | -3.83% | 10b5-1 | Stalk |
| Mar 18, 2024 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 7,530 | $15.82 | $6.0B | -28.70% | +215.63% | $119.1K | -1.70% | 10b5-1 | Stalk |
| Mar 18, 2024 | Sell | LQDA | Russell Schundler | General Counsel | 8,653 | $15.82 | $6.0B | -28.70% | +215.63% | $136.9K | -0.86% | 10b5-1 | Stalk |
| Mar 18, 2024 | Sell | LQDA | Michael Kaseta | CFO and COO | 12,166 | $15.82 | $6.0B | -28.70% | +215.63% | $192.5K | -1.79% | 10b5-1 | Stalk |
| Mar 18, 2024 | Sell | LQDA | Roger Jeffs | Chief Executive Officer | 28,583 | $15.82 | $6.0B | -28.70% | +215.63% | $452.2K | -3.31% | 10b5-1 | Stalk |
| Feb 29, 2024 | Sell | LQDA | Jason Adair | Chief Business Officer | 455 | $14.17 | $6.0B | -28.70% | +215.63% | $6.4K | -0.41% | — | Stalk |
| Feb 29, 2024 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 546 | $14.17 | $6.0B | -28.70% | +215.63% | $7.7K | -0.31% | 10b5-1 | Stalk |
| Dec 18, 2023 | Sell | LQDA | Jason Adair | Chief Business Officer | 77 | $7.70 | $6.0B | -28.70% | +215.63% | $592.9 | -0.14% | — | Stalk |
| Dec 18, 2023 | Sell | LQDA | Rajeev Saggar | Chief Medical Officer | 14,887 | $7.42 | $6.0B | -28.70% | +215.63% | $110.5K | -8.32% | — | Stalk |
| Dec 14, 2023 | Buy | LQDA | Roger Jeffs | Chief Executive Officer | 139,665 | $7.16 | $6.0B | -28.70% | +215.63% | $1.0M | +27.87% | — | Stalk |
| Nov 30, 2023 | Sell | LQDA | Jason Adair | Chief Business Officer | 452 | $7.28 | $6.0B | -28.70% | +215.63% | $3.3K | -0.66% | — | Stalk |
| Nov 30, 2023 | Sell | LQDA | Robert A Lippe | Chief Operations Officer | 497 | $7.28 | $6.0B | -28.70% | +215.63% | $3.6K | -0.24% | 10b5-1 | Stalk |
| Nov 30, 2023 | Sell | LQDA | Scott Moomaw | Chief Commercial Officer | 542 | $7.28 | $6.0B | -28.70% | +215.63% | $3.9K | -0.44% | 10b5-1 | Stalk |
| Sep 19, 2023 | Sell | LQDA | Jason Adair | Chief Business Officer | 75 | $6.51 | $6.0B | -28.70% | +215.63% | $488.25 | -0.13% | — | Stalk |